SCN5A and Ventricular arrhythmia: The study authors concluded that AS may be associated with SCN5A variants with loss of function and that patients may experience atrial and ventricular arrhythmias and may present with problems during device placement; in addition, patients without atrial pacing capability are at risk for thromboembolic events and deserve anticoagulation [46].